ASSURANS 10MG/12.5ML INJECTION
| Brand Name | Assurans |
| Dosage Form | Injection |
| Strength | 10 mg / 12.5 ml |
| Active Ingredient | Sildenafil Citrate |
| Therapeutic Class | Phosphodiesterase-5 Inhibitor |
| Indication | Erectile Dysfunction, Pulmonary Arterial Hypertension |
| Route of Administration | Intravenous / Intramuscular |
| Prescription | Required |
| Storage | Store at 2β8Β°C, protect from light |
| Packaging | Vial for injection |
ASSURANS 10MG/12.5ML INJECTION
Assurans 10mg/12.5ml Injection contains Sildenafil Citrate, a pharmaceutical product used to treat erectile dysfunction (ED) and, in certain formulations, pulmonary arterial hypertension (PAH). This injectable solution provides rapid onset of action compared to oral formulations, making it ideal for patients requiring fast and effective management under medical supervision.
Sildenafil works by selectively inhibiting the enzyme phosphodiesterase type 5 (PDE5), which enhances blood flow to specific tissues. In men, this helps achieve and maintain an erection suitable for sexual activity. When used for PAH, Sildenafil relaxes blood vessels in the lungs, reducing pulmonary blood pressure and improving exercise capacity. The injection is administered intravenously or intramuscularly, strictly under the guidance of a healthcare professional for safe and precise dosing.
As a trusted pharmaceutical therapy, Assurans 10mg/12.5ml Injection ensures consistent and reliable results. Its rapid absorption and precise dosing support better patient compliance and improved outcomes. Widely used in hospitals and clinics, it offers a convenient alternative to oral tablets for patients requiring prompt action or those with swallowing difficulties.
Product Features
- Contains Sildenafil Citrate 10 mg per 12.5 ml
- Rapid-acting injectable formulation
- Treats erectile dysfunction and pulmonary arterial hypertension
- Administered under medical supervision
- Ensures fast and effective therapeutic response
How It Helps
- Improves blood flow to penile tissue for ED
- Enhances exercise capacity in PAH patients
- Provides rapid onset compared to oral tablets
- Supports better treatment compliance and outcomes

Reviews
There are no reviews yet.